Tag:
VEGF Trap-Eye
Latest Headlines
Latest Headlines
Bayer predicts blockbuster success for four of its late-stage drugs
You can count Bayer among the Big Pharma companies unwilling to back down from their multibillion-dollar gambles on drug research. The company boldly predicted that four of its late-stage programs
Sanofi and Regeneron hit goals in RA drug study
Regeneron appears to be on a roll. Just weeks after an FDA panel backed its eye drug for approval, the company ( $REGN ) and French drug giant Sanofi ($SNY) have shown that an experimental antibody
UPDATED: Regeneron eye drug gets green flag at AdComm
Regeneron Pharmaceuticals ( $REGN ) has passed a key test at an FDA advisory committee meeting on its experimental eye drug. The expert panel voted unanimously that the treatment, called VEGF Trap-Eye,
What's the best strategy for working with FDA regulators?
Today FDA staffers published an even-handed evaluation of VEGF Trap Eye ( aflibercept ). As Bloomberg reports, the drug helps prevent vision loss just as well as a rival treatment on the market. And it
Regeneron AMD drug beats Lucentis on dosing in PhIII
Barreling toward regulatory filings in the U.S. and Europe, Regeneron says its experimental AMD drug performed as well as Lucentis in two late-stage trials, with half of the direct injections in the
